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ARTICLE OPEN
Heart regeneration in the salamander relies on macrophage-
mediated control of ﬁbroblast activation and the extracellular
landscape
J. W. Godwin1,2,3, R. Debuque2, E. Salimova2 and N. A. Rosenthal1,2,4
In dramatic contrast to the poor repair outcomes for humans and rodent models such as mice, salamanders and some ﬁsh species
are able to completely regenerate heart tissue following tissue injury, at any life stage. This capacity for complete cardiac repair
provides a template for understanding the process of regeneration and for developing strategies to improve human cardiac repair
outcomes. Using a cardiac cryo-injury model we show that heart regeneration is dependent on the innate immune system, as
macrophage depletion during early time points post-injury results in regeneration failure. In contrast to the transient extracellular
matrix that normally accompanies regeneration, this intervention resulted in a permanent, highly cross-linked extracellular matrix
scar derived from alternative ﬁbroblast activation and lysyl-oxidase enzyme synthesis. The activation of cardiomyocyte proliferation
was not affected by macrophage depletion, indicating that cardiomyocyte replacement is an independent feature of the
regenerative process, and is not sufﬁcient to prevent ﬁbrotic progression. These ﬁndings highlight the interplay between
macrophages and ﬁbroblasts as an important component of cardiac regeneration, and the prevention of ﬁbrosis as a key
therapeutic target in the promotion of cardiac repair in mammals.
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INTRODUCTION
The adult mammalian heart has very limited capacity for repair
following major insult. Teleost ﬁsh and urodele amphibians (i.e.,
zebraﬁsh and salamanders) are leading models in vertebrate
cardiac regeneration that can regenerate their hearts after
amputation of the ventricle apex throughout their lives,1, 2
rebuilding a new compact myocardial layer and undergoing full
regeneration of up to 20% of organ mass within 2 months. These
species respond to tissue loss without scarring, producing new
tissue that restores complete function.2–4 The ability of the adult
ﬁsh and salamander heart to replace and re-pattern lost cardiac
tissue appears be a capricious evolutionary variable; in the non-
urodele amphibian adult, cardiac resection leads to little or no
regeneration, leaving ﬁbrosis as the dominant histological reaction
to injury.
As neonates, mammals such as the mouse recapitulate the
dramatic regenerative response of ﬁsh and salamander hearts, but
this property is lost shortly after birth,5 suggesting that although
we retain the necessary genetic programming for cardiac
regeneration, other features of the adult mammalian heart
intervene to suppress these programs in adulthood. Although
our own compromised cardiac regenerative capacity has been
attributed largely to the incapacity of adult cardiomyocytes to
proliferate after injury and contribute to tissue repair, it is
increasingly evident that ﬁbrosis plays a central role in impeding
cardiac tissue replacement in the adult mammalian heart.6–8
Myocardial infarction (MI), results in necrotic lesions where
removal of dead tissue and remodeling in the wound site is not
accompanied by tissue regeneration, leading to heart failure and
arrhythmias.9 Initial inﬂammation is critical for clearance of tissue
debris, stabilization and strengthening of the myocardial wall and
prevention of cardiac rupture, yet persistent inﬂammation leads to
scar formation, functional compromise and ultimately heart
failure.6, 10, 11 Thus the orchestration of the inﬂammatory response
and its resolution is a key factor in effective cardiac regeneration
that appears to have been lost both in ontogeny (regeneration of
neonatal vs. adult mammalian hearts) and phylogeny (regenera-
tion of ﬁsh and salamander vs. mammalian hearts).12
The immune response to injury is a major factor controlling
tissue repair in a range of mammalian wound healing contexts. In
the neonatal mouse heart, which fully recovers from injury,5
cardiac regeneration depends on the action of macrophages, as
their depletion blocks repair and leads to ﬁbrosis typical of adult
mammalian cardiac damage response.13 We have previously
documented an early requirement of macrophages for the
successful limb regeneration in axolotl, a urodele amphibian,14
which relies on dedifferentiation of mature tissues in an
epimorphic process to form a mound of proliferating cells called
a blastema. Muscle cells in the axolotl are formed in the new limb
almost exclusively from resident muscle progenitor cells Pax7+
whereas other urodele species (newts) also use the process of
myocyte dedifferentiation.15 In the axolotl, cardiac regeneration
depends on the proliferation of existing cardiomyocytes to replace
the damaged myocardium,16 but it is unknown whether this
process is dependent on immune signaling.
Using the axolotl, we established a cardiac cryo-injury model
which induces a necrotic ischemic injury, more accurately
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recapitulating many hallmarks of clinical ischemia including
cardiomyocyte (CM) death and macrovascular reperfusion9
compared to the more widely studied resection model. Cryo-
injured ﬁsh and salamander ventricles regenerate without the
involvement of compact scar tissue but form a transient
collagenous network that allow activated cardiomyocytes to
migrate into and repair the heart muscle wall.17 Here, we show
that in the adult axolotl, depleting macrophages in the context of
cardiac cryo-injury limits ﬁbroblast activation, modiﬁes extracel-
lular matrix (ECM) synthesis, remodelling, and cross-linking
proﬁles, and blocks regeneration despite the continued prolifera-
tion of activated cardiomyocytes. These results reveal that tissue
regeneration in the heart is dependent on an ECM structure and
composition that is compatible with cardiac muscle replacement,
and that macrophages may play a critical role in preventing
precocious ECM maturation.
RESULTS
Necrotic cryo-injuries are regenerated in axolotls
Damage to the heart ventricle by puncture or resection in both
newt and axolotl salamanders results in transient ECM synthesis
and functional replacement of missing or damaged cardiomyo-
cytes, epicardium, endothelium and connective tissue cells.16, 18, 19
In an alternate approach similar to that developed in mice and
zebraﬁsh9, 17, 20 we used a liquid nitrogen cooled gold probe to
reproducibly induce targeted tissue damage on the ventricle wall
in order to monitor healing and repair over the time course of
regeneration (Fig. 1a, b). The cryo-lesion resulted in tissue damage
and necrosis (Fig. 1c), requiring debridement and cell replace-
ment. Robust inﬁltration of nucleated cells was consistent with
invasion of inﬂammatory leukocytes (Fig. 1d). Cryo-injuries were
completely repaired by 60–90 days (Fig. 1e–g) similar to that
reported for ventricular resection.16
Regeneration relies on cardiomyocyte proliferation in a temporal
sequence of activation
Heart regeneration in the salamander involves the activation of
cardiomyocyte proliferation. We assessed the time-course for
proliferation in the cryo-injured heart by assessing Bromodeox-
yuridine (BrdU) incorporation in both cardiomyocytes (Nkx2.5+ve)
vs. non-cardiomyocyte (Nkx2.5−ve) populations in each week
following cardiac cryo-injury (Fig. 1h–j). A distinct sequence for
proliferation was observed, starting with epicardial activation and
a burst of proliferation in the valve region in week 1 (Fig. 1k). As
seen in ﬁsh cardiac injury response,21 epicardial proliferation was
observed globally and not limited to the injury site. In week 2,
cardiomyocyte proliferation was increased and mainly restricted
to the border zone of the injury site, accompanied by continued
cell proliferation in the epicardium. In week 3, cardiomyoyte
proliferation peaked in a dense layer around the injury border
zone with a scattering of cardiomyocyte proliferation extending
into remote regions of the ventricle. Proliferation continued to
decline until regeneration was complete (Fig. 1j).
Macrophage depletion prior to cardiac cryo-injury results in
impaired cardiac function and poor survival
To test the dependence of adult axolotl heart regeneration on
macrophage function we employed a clodronate loaded liposome
(Clo-Lipo) macrophage depletion regimen that eliminates macro-
phages from all major organs after three i.v. injections over
4 days.14 This procedure depletes resident macrophages from liver
and spleen due to access via the fenestrated vasculature.
Although the depletion of cardiac resident macrophages may
not be absolute, the enhanced trabeculation of the salamander
heart, relative to the mouse, does provide enhanced access of
clodornate liposomes to resident macrophages. Axolotl hearts
were cryo-injured during a Clo-Lipo macrophage-depleted win-
dow of around 7–10 days before macrophage repopulation arises
from myelopoiesis (Fig. 2a, Supp. Fig. 1A). Cryo-lesions were
located by the absence of cardiac troponin T within the ventricle,
and reduction in macrophage accumulation was identiﬁed by the
speciﬁc macrophage marker Isolectin-B422 (Fig. 2b, Supp. Fig. 1A).
Clo-Lipo macrophage depletion altered the production of key ECM
proteins (Tenascin C, Collagen-I and Fibronectin) within the lesion
site when compared with the phosphate buffered saline loaded
liposome (PBS-Lipo) control animals (Fig. 2c, d, Supp. Fig. 1B).
The effect of cryo-injuring the axolotl heart in the absence of
macrophages was dramatic, with progressive scarring occurring in
macrophage depleted hearts evident at 25, 50, and 90-days post-
injury (Fig. 3a), accompanied by a change in ventricular function
assessed by ultrasound analysis (Fig. 3b). Fractional Area Change
(FAC) was used as a functional parameter. %FAC was signiﬁcantly
reduced at 14 days relative to uninjured in both PBS injected
animals and Clo-Lipo treated animals (Fig. 3c). The PBS-Lipo
treated animals showed functional recovery by 45 days whereas
Clo-Lipo treated animals showed reduction in functional improve-
ment at 45-days relative to uninjured and PBS injected animals.
Similar results were obtained using independent LV(LeftVentricu-
lar)-trace mode that allows for volumetric calculations (e.g., %EF
and stroke volume) calculations (Data not shown). Long-term
animal survival was also severely impacted in Clo-Lipo treated
animals despite restoration of macrophage function around 10-
days post-injury (Fig. 3d). This mortality was not observed in limb
regeneration model using the same Clo-Lipo regimen.14 Macro-
phage depletion placed the short-term survival at risk from
infection post injury, however the impacts on long-term survival
were likely related to heart failure as no signs of infection were
observed in these animals.
Macrophage depletion results in disruption of the regeneration
program by induction of ﬁbroblast activation and alternative ECM
proﬁle
To determine the processes leading to the dramatic scar tissue
accumulation and lack of collagen remodeling back to normal
tissue in macrophage-depleted hearts, we ﬁrst characterized ECM
components that were up-regulated following cryo-injury in both
PBS-Lipo control animals and macrophage depleted Clo-Lipo
animals. The region of cryo-injury was determined by the
depletion of cardiac troponin T staining and sarcomeric myosin
in injured cardiomyocytes (see Fig. 2b). Using this landmark, we
assessed that ﬁbronectin was speciﬁcally up-regulated within the
lesion site in control animals but a muted response is observed in
macrophage depleted animals (Fig. 2d), accompanied by robust
induction of Alpha-Smooth Muscle Actin (αSMA) positive cells
within the lesion (Fig. 4a Supp. Fig. 1A). In PBS-Lipo control
animals (αSMA) positive cells were conﬁned to the epithelial
region and were absent within the lesion. Discoidin domain
receptor 2 (DDR2) positive cells were also present speciﬁcally in
Clo-Lipo treated animals (Fig. 4b, Supp. Fig. 1A). These represent
highly conserved and speciﬁc markers for activated subsets of
ﬁbroblasts associated with the promotion of collagen synthesis
and ﬁbrosis.23 Macrophage depletion also produced changes in
collagen deposition and arrangement as measured by picosirius
red and polarized light, consistent with the limb regeneration
model (Fig. 4c).
Macrophages play an important role in regulating new blood
vessel and lymphatic vessel growth in many species. To determine
whether the lack of macrophages during the early phase of injury
affected vessel sprouting at 14 days post injury, we stained von
Wilebrand factor (vWF) positive endothelial cells to reveal blood
vessel sprouting Fig. 5a–b) maintained at a low level within the
cryo-lesion wound margins of Clo-Lipo animals, but vessel density
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was severely reduced relative to PBS-Lipo treated animals (Supp.
Fig. 1B).
Insulin-like growth factor 1 (IGF-1) is a major driver of heart
repair and some isoforms are produced by macrophages.24
Expression of the IGF-1 ligand was weakly maintained in the
epicardium but was noticeably absent in the remainder of the
lesion in macrophage-depleted animals (Fig. 5c, Supp. Fig. 1B).
Interestingly, the IGF1 Receptor was upregulated in cardiomyo-
cytes at the wound margin in both macrophage-depleted and
control hearts (Fig. 5c, Supp. Fig. 1B), indicating that the failure in
Fig. 1 Proliferation of cardiomyocytes during cardiac regeneration post cryo-injury. a A commercial liquid nitrogen cooled cryo-gun was used
to generate a cryo-lesion at the apex of the heart. b Different gold tip attachments allowed matching to animal size. c A necrotic lesion was
produced with edema still present at 6-days post injury (Dpi). d The lesion was identiﬁed by a robust inﬂammatory inﬁltrate with visible
peripheral nuclei (DAPI) at 6 dpi. The ventricle was fully regenerated by 60–90 dpi and appeared normal, both superﬁcially e, and histologically
f, relative to uninjured controls. g Histological staining was performed with Acid Fuchsin orange G (AFOG) whrere collagen stains blue, muscle
of the myocardium in orange/red and the nucleus black. h Time course of Bromodeoxyuridine (BrdU) labelling of animals daily (i.p. injection). i
Identiﬁcation of cardiomyocyte (CM) speciﬁc proliferation used nuclear localized Nk2.5 antibody staining and dual positive BrdU+ (Green)+
Nkx2.5+ cells (Red). j CM speciﬁc and non-CM proliferation was measured during the ﬁrst 5 weeks of regeneration within 200 μM of the
borderzone or 100μM of the valve region (at the junction between the atrium and the ventricle). At least three sections per animal and three
animals per time-point were used. k Cartoon of the general spatial localization of CM and non-CM proliferation in the axolotl heart over the
ﬁrst 3 weeks of regeneration. Non-cardiomyocytes shown in green and Nkx2.5+ CM shown in pink. Cryo lesion in ventricle shown in red. Scale
bar= 100 μM
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regeneration is not likely due to a lack of cardiomyocyte
responsiveness to IGF-1.
Axolotl cardiomyocyte proliferation is maintained despite
regenerative failure
The lack of sufﬁcient cardiomyocyte proliferation in mammals is
generally considered to be a major obstacle to regeneration. To
determine whether macrophage depletion directly affects CM
replenishment by potentially limiting growth factors or cytokine
stimulation, we measured CM proliferation at 7 and 14-days post-
injury in macrophage-depleted axolotl hearts using proliferating
cell nuclear antigen (PCNA) staining of NKx2.5+ cardiomyocytes
(Supp. Fig. 2). These time-points span the period before and
during the initial wave of macrophage replenishment. We found
no signiﬁcant difference in CM proliferation at these time points
(Fig. 5d). The activation of CM proliferation in the absence
of macrophages indicates that CM deﬁciency is not the cause
of regenerative failure in macrophage-depleted cryo-injured
animals.
Fig. 2 ECM deposition during the early healing phase of cardiac regeneration is altered in macrophage-depleted animals. a Macrophage
depletion strategy using Clodronate liposomes (Clo-Lipo) with a triple injection prior to cryo-injury. b Cardiac troponin T staining was absent
within the cryo lesion at 7 dpi. Clo-Lipo treated animals showed almost complete depletion of macrophages (marked by Isolectin B4) in the
cryo-injured heart at 7 dpi relative to PBS-Lipo control animals. c–d Critical components of the transient extracellular matrix (ECM) were
dysregulated in Clo-Lipo treated animals at 7 dpi relative to PBS-Lipo control animals. Collagen I, was up-regulated and muted expression of
Tenascin C and ﬁbronectin is observed. Scale bar= 100 μM
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Fibroblast activation and enzymatic ECM crosslinking causes
regenerative failure in the axolotl
To determine a possible mechanism whereby transient ECM
deposition could be converted to a permanent scar, molecular
analysis was conducted on the heart ventricle of both control and
macrophage-depleted animals. Colony stimulating factor 1
receptor gene expression conﬁrmed efﬁcient depletion of
macrophages where myeloperoxidase gene was maintained
indicating a normal neutrophil response. (Fig. 6). Discoidin
Domain Receptor Tyrosine Kinase 2 (DDR2) and Collagen-I up-
regulation was detectable in the Clo-Lipo treated animals
conﬁrming immuno-histochemical analysis. Vimentin marks all
ﬁbroblasts in the axolotl and the vimentin transcriptional signal
indicated that the number of ﬁbroblasts in the heart was not
signiﬁcantly affected. Post-injury, Dipeptidyl peptidase-4 was
downregulated in macrophage-depleted lesions, implicating a
conserved role as a macrophage-dependent protease in wound
remodeling. Transforming growth factor beta (TGFβ) expression
was elevated in macrophage-depleted animals, whereas Matrix
metaloproteinase (MMP) enzymes MMP2, MMP19 were upregu-
lated, MMP3 was signiﬁcantly down-regulated and MMP9 was not
signiﬁcantly changed. This implicates MMP3 as the major
macrophage-dependent MMP, while expression from neutrophils
may compensate for other MMPs. The molecular pathways
responsible for the highly cross-linked ECM phenotype likely
include a gene group belonging to the Lysl-oxidase enzyme family
(LOX) involved in collagen crosslinking and tissue maturation,
which showed high dysregulation across several family members,
while other pathways that were not affected included Transglu-
taminase 2 involved in ﬁbrosis, and Aldehyde Dehydrogenase 3
Family Member A2 involved in retinoic acid synthesis (Fig. 6).
DISCUSSION
This study highlights the central role of ﬁbrotic pathways in
limiting efﬁcient cardiac repair, and demonstrates an immediate
requirement for macrophages in regeneration of adult cardiac
tissue, as their ablation at early time-points has lasting effects on
the outcome of the cardiac injury response: progressive ﬁbrosis
results in defective cardiac regeneration and abrogates functional
recovery. The detection of activated ﬁbroblasts or myoﬁbroblasts
at very early stages of repair in macrophage-depleted animals
Fig. 3 Macrophage depletion results in progressive scar formation and regenerative failure. a AFOG staining of Clo-Lipo macrophage
depleted animals vs. PBS-Lipo control animals over the normal time-course of regeneration. Collagen deposition (blue) and ﬁbrosis developed
in the absence of macrophages and was not remodeled. b Ultrasound examination of the hearts post cryo-injury in macrophage depleted and
normal animals. Representative end systolic (top) and end diastolic (bottom) images of the ventricles in the maximal longitudinal plane. Trace
of the ventricle is shown in dashed blue line. Diameter marked with yellow and length with red overlays. c Assessment of cardiac performance
based on calculations of % Fractional Area Change (%FAC). Cryoinjury results in a signiﬁcant %FAC reduction in both Clo-Lipo and PBS-Lipo
treated animals relative to uninjured control at 14 dpi. PBS-Lipo control animals regained normal function by 45 dpi while Clo-Lipo animal
hearts remained compromised. d Clo-Lipo treatment altered animal survival post-cryo-surgery in two major phases. Scale bar= 500 μM
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indicates that macrophages are immediately required to control
ﬁbroblast differentiation. Whereas early macrophage depletion
could be expected to affect viability and recovery from surgery
due to associated risk of infection, animals surviving this initial
period are at increased risk at much later time points, coinciding
with progressive ﬁbrosis leading to terminal heart failure. These
results are reminiscent of mammalian MI injury where dilation and
ﬁbrotic progression ultimately destroys heart function,25 and are
consistent with a model inducing unresolved inﬂammation in the
regenerating amphibian limb, where cellular dedifferentiation and
reprogramming still occur locally, but the tissue interactions and
signaling required for limb patterning cannot be established,
leading to regenerative failure.26
In the hearts of macrophage-depleted cryo-injured axolotls,
initiation of CM proliferation was unaffected at 7 and 14-days post-
injury. The fact that the CM response was largely intact in hearts
damaged by the absence of macrophages indicates that CM
proliferation is not the limiting step in axolotl heart regeneration.
Cardiomyocytes at the lesion site functionally responded to injury
by upregulating IGF1R at the borderzone and although IGF-1
expression was reduced in clodronate-induced cryo-lesions, it was
partially maintained in the epicardium, a potent source of growth
factor signaling in the zebraﬁsh.27 It is therefore possible that
epicardially derived growth factors are sufﬁcient to maintain CM
proliferation in the cro-injured axolotl heart.
Macrophages play an essential role in many injury contexts
by supporting angiogenesis through expression of Vascular
endothleial growth factor A.28, 29 We observed changes in
vWF+ endothelial populations between macrophage depleted
and control cryo-lesions. This supports a role for macrophage-
dependent angiogenesis although it is not known if the new
blood vessel growth arises from sprouting or from epicardial
derived endothelial progenitors in this model.30 At 10 days after
clodronate treatment, macrophage populations are largely
restored in axolotls, at which point any pro-angiogenic functions
are likely impacted by rigid ﬁbrotic ECM associated with early
macrophage depletion. New blood vessel growth is likely to
impact the speed of regeneration in axolotls however the thin
trabeculated (non-compacted) structure of the myocardium likely
allows some access of oxygenated blood to the injured tissue.
Therefore is is possible that angiogenisis may not be an absolute
requirement for allowing the regeneration of an amphibian heart.
Future studies should be aimed at testing the requirement for
neoangiogenesis in a non-ﬁbrotic alternative model.
The lack of macrophages in early cryo-lesions does not result in
cardiac rupture but alters the ECM landscape, presumably through
the activation state of attending connective tissue cells. The
progressive nature of ﬁbrosis that appears with cryo-lesions in
clodronate-treated animals presumably stems from the early
activation of myoﬁbroblasts within the wound and the down-
stream accumulation of collagen deposition. The differentiation of
ﬁbroblasts and other precursor cells into myoﬁbroblast popula-
tions is a major driver of the ﬁbrotic response in humans and
other mammals.31–33 Normal regeneration activates myoﬁbroblast
conversion in the epicardium but the depletion of macrophages
results in ﬁbroblast activation (alpha SMA+ cells) not normally
found within the lesioned site. This observation gives weight to
the notion that wound macrophages act as a negative regulator of
ﬁbroblast differentiation. In this study it is unclear the exact origin
Fig. 4 Macrophage depleted animals feature enhanced ﬁbroblast
differentiation and collagen maturation. a Alpha smooth muscle
actin (αSMA) positive myoﬁbroblasts populated the cryo-lesion in
Clo-Lipo treated animals where αSMA + cells were restricted to the
epicardium in PBS-Lipo control lesioned animals at 7 dpi. b Discoidin
Domain Receptor Tyrosine Kinase 2 (DDR2) expression was up-
regulated in Clo-Lipo treated animals 7 dpi at different sites at along
the wound margin. c Dissected 14 dpi cryo-injured whole mounted
hearts imaged under a polarizing lens at maximum contrast. Clo-
Lipo hearts showed enhanced accumulation of cross-linked collagen
(top panel) Picrosirius red stained sections visualized under
polarized light showed accumulation of thick collagen bundles in
Clo-Lipo treated animals at 14 dpi. Scale bar= 100 μM
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of the participating macrophages and if regulatory function is
restrictied to a particular subpopulation. In mammals, myoﬁbro-
blasts are derived from a range of progenitors.34, 35 It is not known
if these cell types can act as a source of myoﬁbroblasts in
salamander tissues or how the lack of macrophages may enhance
ﬁbroblast differentiation.
The histological identiﬁcation of DDR2+ ﬁbroblasts in
macrophage-depleted cryo-lesions, conﬁrmed by Real time PCR
(RT-PCR), suggests that at least a portion of ﬁbroblasts in these
wounds have altered gene expression. DDR2 is a receptor tyrosine
kinase implicated in the regulation of growth, migration, cell
morphology, and differentiation and remodeling of the ECM by
controlling matrix metalloproteinases.23 In mammals, DDR2 is a
marker of mesenchymal cells 36 and is restricted to cardiac
ﬁbroblasts in the adult heart.37 In the mouse, DDR2 expression has
been linked with cardiac ﬁbrosis through multiple pathways,23, 38
as the extracellular discoidin domain of DDR2 binds with high
afﬁnity to immobilized collagen type I.39 It is therefore likely that
DDR2 is an evolutionarily conserved marker for alternatively
activated ﬁbroblasts in the salamander heart. Mesenchymal cells
are endowed with the remarkable ability to respond to environ-
mental signals triggered by injury or infection and phenotypic
Fig. 5 Blood vessel density and IGF signaling in macrophage depleted animals is altered in Clo-Lipo animals where cardiomyocyte
proliferation appears unchanged. a Endothelial cell staining using von Wilebrand Factor (vWF) demonstrated a reduced vascular network in
Clo-Lipo animals at 14 dpi. b higher magniﬁcation of vWF staining at wound margin showed reduction in blood vessel outgrowth. c Insulin-
like Growth Factor (IGF-1) ligand expression was downregulated in Clo-Lipo injured hearts at 14 dpi with weak epicardial expression
maintained. Conversely, IGF-1-Receptor expression was upregulated speciﬁcally in cardiomyocytes (CMs) at the wound margin
and maintained in Clo-Lipo treated animals. d CM proliferation was measured using PCNA+ Nkx2.5+ cells on 7 and 15 dpi hearts and
no signiﬁcant difference was detected. CM proliferation measured using at least three sections per animal and three animals per time-point.
Scale bar= 100 μM
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states, analogous to the macrophage polarization paradigm.40
Dynamic regulatory feedback mechanisms between mesenchymal
and macrophage cell types are now appreciated to be important
for regulating inﬂammation and ﬁbrotic activation in a range of
contexts.41
Cardiac regeneration in salamanders and zebraﬁsh involves the
formation of transient ECM deposition that is distinct from normal
tissue18, 42 and is remodeled in coordination with effective tissue
replacement.43 Although the ﬁbrotic process is extremely complex
due to the dynamic regulation, multiple targets and co-expression
of inhibitors that limit function in certain contexts,44 a range of
candidate genes involved with precocious ECM maturation were
identiﬁed, including MMP3, the major MMP absent in macrophage
depleted animals, and MMP2 and MMP19, which were over-
expressed. MMPs have both inhibitory and stimulatory roles in
ﬁbrosis that vary by tissue and wound healing phase.45 In vitro,
MMP3 activates β-catenin signaling and induces epithelial-to-
mesenchymal (EMT) transition.46 Reduced MMP3 in macrophage-
Fig. 6 Gene expression analysis of macrophage depleted hearts post cryo-injury identiﬁes molecular targets regulating ECM regulation
during regeneration. RT-PCR analysis of 7 dpi cryo-injured hearts isolated from Clo-Lipo and PBS-Lipo control animals. Heart ventricle samples
were screened for a list of candidate genes (partially isolated from previous RNAseq studies) that regulate ECM turnover and maturation
during regeneration. N= 5 animals, at least 3 independent experiments performed. (see Methods section for statistics)
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depleted cryo injured hearts may therefore affect EMT, abrogating
β-catenin signaling.47 MMP2 has been implicated in cardiac
ﬁbrosis, associated with cardiac ﬁbroblasts and myoﬁbroblasts
rather than inﬂammatory leukocytes post-cardiac injury.42, 48
MMP19 overexpression promotes ﬁbrosis at both early injury and
late resolution stages in liver injury where in lung it may play an
anti-ﬁbrotic role.44
TGFβ is a potent activator of myoﬁbroblast induction in many
species and a major regulator of ﬁbrosis in many contexts
including the heart.49 TGFβ is essential for limb regeneration in
the salamander50 and it is likely that strict temporal expression is
required to maintain functional regeneration circuits. The upre-
gulation of cardiac TGFβ in the absence of macrophages is in
agreement with results obtained previously in the limb regenera-
tion model (Godwin et al., PNAS 2014). The source of increased
TGFβ production in the absence of macrophages is yet to be
determined but highlights a role for macrophage-speciﬁc cytokine
regulation of TGFβ expression in salamander regeneration.
Our analysis uncovered a potential role for the LOX family of
enzymes in the precocious maturation of the transient regen-
erative ECM, as several members of the LOX enzyme family were
dysregulated in cardiac cryo-lesions in macrophage-depleted
animals. LOX enzymes play an important role in the maturation
of ECM proteins and correct assembly of tissue architecture,
forming cross links between ECM proteins that stabilize ECM
tissues during normal homeostasis.51 The early activation of Lysyl
oxidase (LOX) and lysl oxidase like−1 (LoxL1), and lysyl oxidase like
-4 (LOXL4) but not lysyl oxidase 5a (LOX5a), in the macrophage-
depleted axolotl heart post-cryo-injury suggests that macrophage
signaling is required to prevent early maturation of the transient
ECM required for regeneration. LOXL1 regulates collagen cross-
linking and total collagen levels in angiotensin II-induced
hypertension in rodents,52 has been associated with renal
ﬁbrosis53 When overexpressed, it induces cardiac hypertrophy in
mice.54 LOX enzymes have also been implicated in activation of
TGFβ1 signaling from the latent complex.55 LOXs also contribute
signiﬁcantly to the detrimental effects of cardiac remodeling in
mice following MI56 and as such may represent a common
pathway of ﬁbrotic disruption of repair in a range of evolutionarily
distinct species, Inhibition of LOX signaling may therefore be an
important therapeutic avenue for limiting ﬁbrosis. Notably,
transglutaminase pathways were unaffected by macrophage
depletion. Transglutaminase is reported to promote tissue ﬁbrosis
through cross-linking extracellular collagen and ﬁbronectin,
making them more resistant to breakdown57 along with multiple
other functions that may promote ﬁbrosis.58 The lack of
transglutaminase activation may be another key feature of
effective cardiac regeneration.
Previous studies of cardiac repair in mouse models have been
focused on driving cardiomyocyte proliferation to improve cardiac
regeneration (reviewed in refs. 59–61) In the salamander CM
proliferation is necessary but not sufﬁcient to drive effective
regeneration, suggesting that efforts should be refocused on
understanding the dominant ﬁbroblast signals regulating repair.
The excessive activation of ﬁbroblasts have been implicated as
major determinants of maladaptive repair in a range of
mammalian contexts41 and the injury induced changes in
mesenchymal cell activation appears evolutionarily conserved.
Identifying the mechanism by which macrophage-ﬁbroblast
interactions repress ﬁbrotic activation in the salamander heart
may lead to new molecular targets useful in promoting cardiac
regeneration in humans.
MATERIALS AND METHODS
Animal maintenance and wounding
Axolotl (Ambystoma mexicanum) larvae were maintained in 20%
Holtfreter’s solution at 19–22°C on a 12-h light, 12-h dark cycle. Before
cryo-injury, animals were anesthetized in 0.1% MS-222 (ethyl 3-
aminobenzoate methanesulfonate salt; Sigma-Aldrich, St. Louis, MO). All
animals used were at least 1 year old and measured between 4–10 cm for
immunoﬂuorescence and Echocardiography and RT PCR. 17–20 cm
animals were used for BrdU experiments and Trichrome staining. Animals
were randomly assorted into each group without regard to gender with
sample sizes chosen assuming an equal variance, a power value of 0.8 and
alpha of 0.05. All animal care protocols and methods were performed in
accordance with relevant regulations and guidelines and with approval
from either the Monash University animal ethics committee or MDIBL
animal care and use committee.
Mononuclear phagocyte depletion
Clodronate liposomes and PBS liposomes (control) preparations were
purchased from Encapsula Nano Sciences, (Nashville TN, USA). Method
used were described previously.14 Maximal depletion protocol = (96 + 48 +
24 h prior to analysis) triple injection protocol (3× i.v. injections over 4 days,
prior to injury).
Cryo injury procedure
Animals were anesthetized in 0.05–0.1% MS-222 (ethyl 3-aminobenzoate
methanesulfonate salt; Sigma-Aldrich, St. Louis, MO) and positioned on
moist kimwipes (kimtech) in a supine positon. Skin was cleaned with
chlorohexidine and the heart accessed by keyhole surgery. Brieﬂy, a small
incision was made on the skin and thoracic muscle. Using sterile ﬁne
forceps and iredectomy scissors, the pericardial sac was opened to reveal
the beating heart. A commercial gold probe (Brymill AC-3 with different
sized tip attachments) was cooled by squeezing the lever allowing liquid
nitrogen to cool the tip of the apparatus. The tip of the probe was placed
on the tip of the ventricle for 5 s and then ﬂushed with sterile saline with
1x penicillin/streptomycin to release the probe. A white ring of damaged
tissue was observed that formed the new cryo-lesion. Probe size was
adjusted and hold time optimized for animal size to create a lesion 1/3 of
the ventricle, positioned at the tip. The pericardial sac was either sealed
with vetbond (3 M) or ethilon silk sutures (for animals over 5 cm). The outer
skin was then either sealed with vetbond (3 M) or ethilon silk sutures (for
animals over 5 cm). Animals were recovered in clean 20% Holtfreters
solution with antibiotics for 24 h (50 I.U./mL penicillin and 50 (μg/mL
streptomycin) added to water for up to 7 days for Clo-Lipo and PBS-Lipo
animals).
Echocardiography analysis
Cardiac morphology and function at various stages post cryo-injury was
analyzed using Vevo2100 ultrasound imaging system (FUJIFILM/VisualSo-
nics Inc., Canada) with high frequency linear array transducer (VisualSonics
MS550S, 32–56MHz). Animals were lightly anaesthetized Tricane 0.05%
and placed on the imaging platform in supine position supported by
moistened tissues. Ultrasound transmission gel (Aquasonic, Parker
laboratories, USA) was applied on the thorax. The transducer position
was optimised to capture ventricular cross-sections in maximal long-
itudinal axis. B-mode cine-loop recordings of ventricle motion were
acquired. All measurements and calculations were performed using Vevo®
2100 software and compared using one-way ANOVA. %FAC was calculated
as (Ventricular area; d—Ventricular area; s)/(Ventricular area; d) × 100. %
FAC calculations gave similar results to independent measurements in LV-
trace mode that allows for volumetric calculations (e.g., %EF and stroke
volume). %FAC was chosen as a measurement to report heart function as
LV-trace mode is optimized for the assessment of heart function in small
mammals and in case of the axolotl, should be only regarded as an
approximation. Hearts showing major vascular occlusion, anemia, rupture,
or no clear lesion were eliminated from analysis and animals euthanized.
Histology and immunohistochemistry
For histological and immunohistochemical analysis, tissue cryosections
were prepared by either perfusing tissue with 0.7 × PBS (APBS) then
ﬁxation using freshly prepared 4% formaldehyde for 15mins. The ﬁxed
tissues were submerged in 30% sucrose/PBS for 1 h followed by
embedding with Optimal Cutting Temperature (OCT). Alternatively,
samples were ﬂash frozen in OCT and post-ﬁxed with acetone or methanol
to enhance staining. 18 μm thick sections were prepared before
permeabilization with 0.1% Triton-X-100/PBS for 30min. Sections were
blocked with blocking solution (3% BSA, 1.5% normal donkey serum and
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0.1% Triton-X-100 in PBS) and incubated overnight at 4 °C with primary
antibodies (see antibody section). For histology, samples were ﬁxed
overnight in 4% paraformaldehyde in 0.7 × PBS at 4 °C, then rinsed,
dehydrated, embedded in parafﬁn and sectioned at a thickness of 14 μm.
Before staining, slides were de-parafﬁnized through three baths of xylene
for 5 min each. Slides were then rehydrated in a graded series of 100, 90,
70, and 50% ethanol and then ﬁnally hydrated in distilled water for 5 min
each. Sections were washed and counterstained with DAPI (Sigma) and
mounted in Vectamount ﬂuorescent mounting medium (Vector labs) or
Mowbiol. Confocal microscopy was performed on a Nikon C1, Leica SP8
or Zeiss Axiovert 200M microscope and images processes using Imaris
software (Bitplane). Quantitation of immunoﬂuorescence was done
blinded using a Fiji (image J software).
Cytochemistry
Reagents for Acid Fuchsin Orange G and Picosirius red staining were
purchased from sigma and performed according to standard procedures
(ihcworld.com). Picosirius red analysis was performed on a Leica DM4500
using a polarized ﬁlter set at maximal contrast.
Antibodies
The following antibodies were purchased. Anti Nkx2.5: Abcam (ab35842),
Anti BrdU: Becton Dickinson (B44), Troponin T: DSHB (CT3), Tenascin C:
(DSHB), Anti-Fibronectin antibody: Abcam (ab23750), Anti-Collagen I:
Millipore, Alpha SMA Anti-smooth muscle Actin: Invitrogen (1A4), DDR2:
Santa Cruz (H-108), vWF Anti-von Willebrand factor: Sigma (F3520), IGF-I:
Santa Cruz (H-70), IGF1-receptor beta antibody: Cell Signaling (3027 S),
Anti-PCNA: Dako (PC10). Conjugated Isolectin B4 (IB4): Vectorlabs.
Antibodies were titrated for speciﬁc application. All other secondary
antibodies were purchased from Invitrogen (highly cross absorbed).
RT-PCR gene expression analysis
RNA was isolated from harvested tissue using Trizol reagent (Invitrogen).
Following isolation, RNA was further puriﬁed using the Zymopure RNA
isolation kit with on column DNA digestion. RNA quality was assessed by
spectrophotometry using a NanoDrop ND-1000 (NanoDrop, Wilmington,
USA). Reverse transcription was performed using the Superscript VILO
cDNA synthesis kit (Life technologies). Quantitative PCR assays were
performed using LightCycler 480 SYBR green (Roche) and analyzed using a
LC480 Thermal Cycler instrument (Roche). Gene expression levels were
calculated using the 2−ΔΔCt and were normalized by using the geometric
mean of at least three housekeeping (normalizer) genes. Experiments were
performed at least three times and from three biological replicates. Primer
sequences used in RT-PCR gene expression analysis are listed in Table S1.
Statistical analysis
Data were shown throughout as mean values ± s.e.m. Analyses of
signiﬁcant differences between means were performed using two-tailed
Student’s t-tests or 2-way ANOVA. With Turkeys multiple comparisons test.
Alpha = 0.05. In all cases *P,0.05; **P,0.01., ***P,0.001, ****P,0.0001. NS = not
signiﬁcant.
Data availability
All data are provided in the results section and supplementary information
accompanying this paper.
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